Zidovudine

Zidovudine

Form: Capsules, Tablet and Oral solution

Strength: Capsules: 100 mg, 250 mg, 300mg; Tab: 300 mg; Oral Sol: 10 mg/ ml

Reference Brands: Retrovir®(Us & EU)

Category: Anti Viral

Zidovudine Capsules (AZT), sold under brands like Retrovir® and Zidovir®, are a cornerstone NRTI antiretroviral used in the treatment and prevention of HIV-1 infection. Available in 100 mg to 300 mg strengths, Zidovudine is vital in adult and pediatric regimens and remains widely used in low-resource settings, PMTCT (Prevention of Mother-to-Child Transmission), and post-exposure prophylaxis. On PharmaB2B platforms, healthcare organizations can source WHO-GMP and USFDA-approved Zidovudine in bulk from trusted manufacturers for tenders and global health programs. Cost-effective and clinically proven, Zidovudine continues to play a key role in global HIV/AIDS control strategies.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Amantadine

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.